Erzhi Pill® Repairs Experimental Liver Injury via TSC/mTOR Signaling Pathway Inhibiting Excessive Apoptosis

The present study aimed to investigate the mechanism of hepatoprotective effect of Erzhi Pill (EZP) on the liver injury via observing TSC/mTOR signaling pathway activation. The experimental liver injury was induced by 2-acetylaminofluorene (2-AAF) treatment combined with partial hepatectomy (PH). EZ...

Full description

Bibliographic Details
Main Authors: Bu-gao Zhou, Hai-mei Zhao, Xiu-yun Lu, Xin Wang, Yong Zou, Rong Xu, Hai-yang Yue, Yi Liu, Zheng-yun Zuo, Duan-yong Liu
Format: Article
Language:English
Published: Hindawi Limited 2017-01-01
Series:Evidence-Based Complementary and Alternative Medicine
Online Access:http://dx.doi.org/10.1155/2017/5653643

Similar Items